-
The world's first vaccine injection robot is available
Time of Update: 2021-12-01
Cobi consists of a robotic arm with a storage area for medicine bottles and a screen that interacts with patients .
-
mRNA respiratory syncytial virus vaccine launches global clinical trial
Time of Update: 2021-12-01
In a phase 1 clinical trial conducted in young adults, one month after subjects received a single dose of vaccine (100 μg), the geometric mean titers of neutralizing antibodies against RSV-A or RAV-B increased by 21 times and respectively compared with baseline.
-
Sanyou Medical Ultrasonic Soft Tissue Cutting Hemostatic Equipment Obtained Medical Device Registration Certificate
Time of Update: 2021-12-01
In 2019, Mizuki Canopy participated as an exclusive enterprise in the People’s Republic of China’s pharmaceutical industry standard "Ultrasonic soft tissue cutting hemostatic surgery equipment" (YY/T1750-2020) formulated by the State Food and Drug Administration.
-
ASH Preview: Looking at the XPO1 target from ASH 2021
Time of Update: 2021-12-01
Verdinexor (KPT-335, ATG- 527) SINE is a new compound effective to inhibit the tumor cell lines canine nucleoprotein XPO1, also reduce the level of viral replication, currently in clinical stage Ⅰ .
(2) BIIB-100 is developed a healthy Bo XPO1 inhibitor indicated for amyotrophic lateral sclerosis (ALS), currently in clinical stage Ⅰ .
-
Merck and Enanta terminate HIV and HBV project development due to safety risks
Time of Update: 2021-12-01
" Merck has been working to develop a weekly treatment plan for HIV patients that uses MK-8507 in combination with islatravir.
-
BeiGene Baiyueze® is approved in the EU for the treatment of adult Fahrenheit macroglobulinemia
Time of Update: 2021-12-01
On November 24, BeiGene announced that the European Commission had approved Baiyueze® (Zebutinib) for the treatment of adult patients with Waldenstrom's macroglobulinemia (WM) who had received at least one treatment in the past, or as unsuitable Chemotherapy and immunotherapy are the first-line treatment options for WM patients .
-
Mass production of anti-cancer cells!
Time of Update: 2021-12-01
The culture process requires the addition of immune factors that can stimulate the proliferation of T cells, but this process will also lead to the proliferation of many non-tumor-specific T cells, so we also need a new method to circumvent this limitation .
-
Decades of tracking reveals: This commonly used "fetal protection drug" may double the risk of cancer in future generations
Time of Update: 2021-12-01
However, a new study recently published in the academic journal American Journal of Obstetrics and Gynecology pointed out that exposure to the offspring of 17-OHPC in the uterus may increase the risk of cancer .
-
The oncologist said after suffering from cancer: "I calculate my death rate at 2 in the morning"
Time of Update: 2021-12-01
A 2015 study found that compared with 230 non-medical patients with similar education levels, 46 doctors had no significant difference in choosing breast cancer treatment .
-
"Nature": Zhao Minglei/Liu Lei team reveals the key mechanism of protein degradation
Time of Update: 2021-12-01
This week, in a new study published in Nature, the team of Professor Minglei Zhao from the University of Chicago and the team of Professor Lei Liu from Tsinghua University used protein chemical synthesis technology and cryo-electron microscopy to deeply explore the specific mechanism of ubiquitination.
-
Smart Metabolism Monitoring Platform Unlocks the Code of Chronic Disease
Time of Update: 2021-12-01
In recent years, many studies have shown that the imbalance of energy metabolism is closely related to a series of major chronic non-communicable diseases (hereinafter referred to as chronic diseases) such as diabetes, obesity, cardiovascular disease, cancer, and aging, and strengthen the regulation mechanism of energy metabolism of the body The basic research of China is the key to coping with the challenge of chronic diseases .
-
MASP-2 targeting monoclonal antibody narsoplimab was rejected by the U.S. FDA
Time of Update: 2021-11-16
S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the monoclonal antibody drug narsoplimab (OMS721) Biological Products License Application (BLA): Rejection of approval of narsoplimab for the treatment of hematopoietic stem cells Transplant-related thrombotic microangiopathy (HSCT-TMA) .
-
The second phase of the new crown vaccine data of the high-end vaccine is reviewed and published in The Lancet-Respiratory Diseases
Time of Update: 2021-11-16
This internationally credible source of clinical, public and global health knowledge published the results of a large-scale, double-blind, randomized, placebo-controlled Phase II trial conducted in 11 locations in Taiwan, allowing global researchers, clinicians, and industry leaders And other professionals see high-end vaccines .
-
Scientists achieve "bionic delivery" of arsenic trioxide to treat leukemia
Time of Update: 2021-11-16
Leukemia is a kind of malignant tumor that makes people "disguised", commonly known as "blood cancer" . Arsenic trioxide (ATO) proposed by Chinese scholars has been approved as a drug for the treatm
-
The research group of Professor Qiao Bin of the School of Physics and collaborators proposed a new scheme for generating a quasi-mono-energetic ion beam driven by a powerful petawatt femtosecond laser
Time of Update: 2021-11-16
9" >Professor Qiao Bin’s research group and collaborators from the School of Physics of Peking University and the State Key Laboratory of Nuclear Physics and Nuclear Technology proposed to irradiate a micro-tape target with a powerful femtosecond laser to obtain a peak energy higher than 100 MeV and an energy dissipation of 1%.
-
Korean Ginseng Research Institute announces that red ginseng may have the adjuvant effect of new crown vaccine
Time of Update: 2021-11-16
Last year, the Korean Ginseng Corporation and the International Vaccine Institute (IVI) signed a memorandum of understanding, and the two sides cooperated in the development of immune enhancers and the ingredients required for the use of red ginseng for new crown vaccine research .
-
The new crown vaccine booster significantly increases the antibody response of rhesus monkeys
Time of Update: 2021-11-16
Scientists from the National Institutes of Health, Johns Hopkins University and other institutions said that about 6 months after the macaque was vaccinated with the first dose of the new vaccine, they were injected with the mRNA-1273 new crown vaccine booster, which is targeted at all known The concentration of neutralizing antibodies of the mutant strain of the new coronavirus will increase significantly .
-
The new innate immune mechanism of tuberculosis resistant population to resist Mycobacterium tuberculosis infection
Time of Update: 2021-11-16
Tuberculosis ( tuberculosis , TB ) is a major infectious disease caused by Mycobacterium tuberculosis ( M. tuberculosis , Mtb ) . According to the latest report released by the WHO, in 2020 , ther
-
Fudan University Cancer Research published: A new mechanism for hyperglycemia to promote tumor metastasis through megakaryocytes
Time of Update: 2021-11-16
2021 Nian 9 Yue 17 days, Fudan University, Professor Liu Wen and Yang Yunlong researcher at Cancer Research Online published a report entitled Megakaryocytes mediate hyperglycemia-induced tumor metastasis research results, the researchers found that high blood glucose by affecting megakaryocytes GRP75 the production of platelets Promote tumor metastasis phenotype .
-
The clearest structure diagram of living E. coli so far released
Time of Update: 2021-11-16
The resulting molecular structure image on the surface of the bacteria shows that the entire outer membrane of the bacteria is packed with micropores formed by proteins that allow nutrients to enter but prevent toxins from entering .
Plaques containing glycolipids separate from the protein-rich outer membrane network and form gaps in some places .
